FIVE-YEAR EXPERIENCE OF HIGHLY ACTIVITY ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV-INFECTION

FIVE-YEAR EXPERIENCE OF HIGHLY ACTIVITY ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV-INFECTION

Clinical, immunological and virologic examination of 67 HIV infected children receiving highly activity antiretroviral therapy (HAART) within 12—60 months is conducted. HAART promoted suppression of HIV replication, increase of T-helpers count, reduction of clinical symptoms frequency and its expres...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. B. Denisenko, E. N. Simovanyan
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2015-09-01
Series:	Детские инфекции (Москва)
Subjects:	hiv infection children highly activity antiretroviral therapy
Online Access:	https://detinf.elpub.ru/jour/article/view/109
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)

DYNAMICS OF CLINICAL LABORATORY PARAMETER IN HIV-INFECTED CHILDREN UNDERGOING DIFFERENT PATTERNS OF INITIAL HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: RANDOMIZED CONTROLLED TRIAL
by: V. B. Denisenko, et al.
Published: (2016-02-01)

Affecting factors to effectiveness of starting therapy in children with hiv infection
by: V. B. Denisenko, et al.
Published: (2015-11-01)

Panhypopituitarism in HIV patient receiving antiretroviral therapy
by: Tatyana B. Morgunova, et al.
Published: (2021-12-01)

Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
by: Ya. S. Ulyanova, et al.
Published: (2021-07-01)

Antiretroviral Therapy Complications and Their Correction in HIV-Infected Pregnant Women in the Perioperative Period
by: E. M. Shifman, et al.
Published: (2011-06-01)

Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS
by: E.V. Ryabokon, et al.
Published: (2013-08-01)

Impact of Covid-19 Pandemic Lockdown on Delivery of Antiretroviral Therapy to Persons Living with HIV Infection
by: Akwiwu E.C.*, Akpan P.A., Isong I.K.P., Akpotuzor J.O., Okafor A.O., Abunimye D.A., Etim O.O., Ndem B.N., Edem M.S.
Published: (2020-09-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF OPPORTUNISTIC INFECTIONS IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2015-08-01)

Treatment efficacy and tuberculosis relapses in HIV infected patients with severe immunosuppression who started antiretroviral therapy
by: E. V. Korzh, et al.
Published: (2020-11-01)

Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia
by: Mequanente Dagnaw, et al.
Published: (2023-12-01)

NATURAL HISTORY OF HIV-INFECTION IN CHILDREN WITH THE ROUTE OF INFECTION
by: V. B. Denisenko, et al.
Published: (2015-08-01)

Clinical and immunological characteristics of opportunistic infections in children with the natural course of HIV infection, taking into account the route of infection
by: V. B. Denisenko, et al.
Published: (2022-07-01)

Factors affecting the rate of immunosuppression development in children with HIV infection
by: V. B. Denisenko, et al.
Published: (2022-04-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
by: Oscar Muñoz-Velandia, et al.
Published: (2020-09-01)

PROBLEMATIC ISSUES OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS WITH ENDOGENOUS MENTAL DISORDERS
by: N. G. Neznanov, et al.
Published: (2017-04-01)

Nosocomial infections in HIV-infected and HIV-uninfected children hospitalised for tuberculosis
by: Ann Robinson, et al.
Published: (2007-07-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF HIV-INFECTION IN DYNAMICS AGAINST THE BACKGROUND OF ANTIRETROVIRAL THERAPY AMONG PATIENTS IN POLTAVA REGION
by: O.H. Marchenko, et al.
Published: (2019-12-01)

Association between antiretroviral therapy and dental caries in children and adolescents with HIV: a systematic review and meta-analysis
by: Rubén Aguirre-Ipenza, et al.
Published: (2025-05-01)

ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA
by: Elamin H. Elbasha, et al.
Published: (2015-09-01)

HIV Infection and Antiretroviral Therapy Impair Liver Function in People Living with HIV: Systematic Review and Meta-Analysis
by: Kay-Lee E. Strauss, et al.
Published: (2025-06-01)

Virological failure of antiretroviral therapy and associated social and clinical factors in children and adolescents living with HIV
by: A. Yu. Sambyalova, et al.
Published: (2023-01-01)

Adherence to HIV antiretroviral therapy
by: A. Heyer, et al.
Published: (2006-09-01)

Maintaining infants and children on highly active antiretroviral therapy
by: Helena Rabie, et al.
Published: (2006-09-01)

Is there still a role for Caesarean section in preventing vertical HIV transmission in the era of highly active antiretroviral therapy?
by: H.M. Sebitloane
Published: (2013-04-01)

HIV drug resistance in children and adolescents on NNRTI-based antiretroviral therapy and subsequent virologic response to dolutegravir-based regimens in Ghana
by: Adwoa K.A Afrane, et al.
Published: (2025-07-01)

Incidence and predictors of common opportunistic infections among children less than 15 years of age on antiretroviral therapy in Ethiopia: a systematic review and meta-analysis
by: Muluken Amare Wudu, et al.
Published: (2025-04-01)

Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
by: Tung-Che Hung, et al.
Published: (2020-08-01)

Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria
by: Samuel A. Olowookere, et al.
Published: (2008-10-01)

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
by: S. Yu. Degtyareva, et al.
Published: (2019-04-01)

Immunopathogenetic significance of activation and apoptosis of immunocompetent cells in children with HIV infection
by: V. B. Denisenko, et al.
Published: (2020-10-01)

The experience of the Bela Bela HIV prevention group with the roll out of Antiretroviral therapy at the Primary Health Care level
by: N.O. Ndjeka, et al.
Published: (2006-05-01)

HIV INFECTION AS A RISK FACTOR OF TUBERCULOSIS IN CHILDREN
by: E. P. Eremenko, et al.
Published: (2017-01-01)

The human gut microbiome and its metabolic pathway dynamics before and during HIV antiretroviral therapy
by: Oumar Dolo, et al.
Published: (2025-08-01)

Analysis of survival of HIV-infected patients depending on various factors
by: D. M. Urunova, et al.
Published: (2024-12-01)

Clinical and immunological characteristic and dynamic of the secondary diseases stage of HIV infection in children, taking into account the route of infection
by: V. B. Denisenko, et al.
Published: (2021-10-01)

Factors Related to Delayed Antiretroviral Therapy Initiation in HIV Patients
by: Dwi Rahayu NLP, et al.
Published: (2016-09-01)